![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Expands Evoke Neuroscience System Use Indications
FDA Expands Evoke Neuroscience System Use Indications
January 4, 2018
Evoke Neuroscience achieved 510(k) marketing clearance to expand the indications for use on its eVox System.
The new indications are electroencephalography and event-related potentials to aid in clinical diagnoses.
The device enables physicians to assess patients’ memory loss using the biomarkers it acquires.
Upcoming Events
-
21Oct